On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

Diabetes management has come a long way, with treatment options now as varied as they are effective. No longer limited to ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

Analyst Jeff Johnson from Robert W. Baird maintained a Buy rating on Insulet (PODD – Research Report) and keeping the price target at ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Q3 2024 Earnings Call Transcript November 6, 2024 Tandem Diabetes Care, Inc. beats earnings expectations. Reported EPS is $-0 ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

I began to plan for their care and well-being if I were to die soon. Consequently, I realized that my only option was to try an insulin pump, a prospect that filled me with dread. I got an emergency ...

While stops are useful, there are inherent problems that can be overcome by using options as an alternative. When you compare stops and options side by side, options have properties that are ...

2 Insulin therapy is necessary for people with T1D and for many living with type 2 diabetes (T2D) or other types of the condition (such as gestational diabetes). Waste from diabetes care includes ...